Cover Image

Icariin restrains NLRP3 inflammasome-mediated Th2 immune responses and ameliorates atopic dermatitis through modulating a novel lncRNA MALAT1/miR-124-3p axis

AbstractContext Atopic dermatitis (AD) is a common inflammatory skin disease characterized with hyperactivation of type 2 T helper (Th2) immune responses. Icariin is a flavonoid glucoside with anti-inflammatory activities, which has been used to treat multiple diseases.Objective The present study in...

Full description

Saved in:

Bibliographic Details
Main Authors:	Wei Zhao (Author), Huan-Huan Yu (Author), Wei-Wei Meng (Author), Ai-Min Liu (Author), Bu-Xin Zhang (Author), Ying Wang (Author), Jie Li (Author), Li Wang (Author), Yu-Fu Fang (Author)
Format:	Book
Published:	Taylor & Francis Group, 2023-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Panax notoginseng saponins inhibits NLRP3 inflammasome-mediated pyroptosis by downregulating lncRNA-ANRIL in cardiorenal syndrome type 4
by: Ying Xu, et al.
Published: (2023)

Gallic Acid Suppressed Tumorigenesis by an LncRNA MALAT1-Wnt/β-Catenin Axis in Hepatocellular Carcinoma
by: Chuan-jian Shi, et al.
Published: (2021)

Functions and mechanisms of lncRNA MALAT1 in cancer chemotherapy resistance
by: Junhui Hou, et al.
Published: (2023)

LncRNA MHRT Prevents Angiotensin II-Induced Myocardial Oxidative Stress and NLRP3 Inflammasome via Nrf2 Activation
by: Pinyi Liu, et al.
Published: (2023)

Chalcone Derivatives From Abelmoschus manihot Seeds Restrain NLRP3 Inflammasome Assembly by Inhibiting ASC Oligomerization
by: Jinsong Su, et al.
Published: (2022)

LncRNA MALAT-1 regulates the growth of interleukin-22-stimulated keratinocytes via the miR-330-5p/S100A7 axis
by: Yu Zhou, et al.
Published: (2022)

lncRNA MALAT1 Promotes Renal Fibrosis in Diabetic Nephropathy by Targeting the miR-2355-3p/IL6ST Axis
by: Haozi Huang, et al.
Published: (2021)

Nuclear-Encoded lncRNA MALAT1 Epigenetically Controls Metabolic Reprogramming in HCC Cells through the Mitophagy Pathway
by: Yijing Zhao, et al.
Published: (2021)

Natural Products that Target the NLRP3 Inflammasome to Treat Fibrosis
by: Nan Ding, et al.
Published: (2020)

NLRP3 inflammasome in metabolic syndrome
by: Fang Wang, et al.
Published: (2021)

Silencing of lncRNA MALAT1 Prevents Inflammatory Injury after Lung Transplant Ischemia-Reperfusion by Downregulation of IL-8 via p300
by: Li Wei, et al.
Published: (2019)

Exercise Reduces Insulin Resistance in Type 2 Diabetes Mellitus via Mediating the lncRNA MALAT1/MicroRNA-382-3p/Resistin Axis
by: Sui-Xin Liu, et al.
Published: (2019)

Tanshinone I specifically suppresses NLRP3 inflammasome activation by disrupting the association of NLRP3 and ASC
by: Jia Zhao, et al.
Published: (2023)

Blocking lncRNA MALAT1/miR-199a/ZHX1 Axis Inhibits Glioblastoma Proliferation and Progression
by: Keman Liao, et al.
Published: (2019)

The role of NLRP3 inflammasome in the pathogenesis of rheumatic disease
by: Ruixue Kong, et al.
Published: (2022)

The NLRP3 Inflammasome in Non-Alcoholic Fatty Liver Disease and Steatohepatitis: Therapeutic Targets and Treatment
by: Lili Yu, et al.
Published: (2022)

LncRNA MDRL Mitigates Atherosclerosis through miR-361/SQSTM1/NLRP3 Signaling
by: Ling You, et al.
Published: (2022)

lncRNA MALAT1 Accelerates Wound Healing of Diabetic Mice Transfused with Modified Autologous Blood via the HIF-1α Signaling Pathway
by: Xiao-Qian Liu, et al.
Published: (2019)

The Role of NLRP3 Inflammasome Signaling on Arrhythmias in Diabetes
by: Zhang L, et al.
Published: (2022)

Activation of Platelet NLRP3 Inflammasome in Crohn's Disease
by: Ge Zhang, et al.
Published: (2021)

Identification of ethyl pyruvate as a NLRP3 inflammasome inhibitor that preserves mitochondrial integrity
by: Sujun Li, et al.
Published: (2018)

The crosstalk between NLRP3 inflammasome and gut microbiome in atherosclerosis
by: Xiao-Nan Zhang, et al.
Published: (2022)

Icariin alleviates rheumatoid arthritis via regulating miR-223-3p/NLRP3 signalling axis
by: Zhi-Ming Wu, et al.
Published: (2020)

Acute Lung Injury and the NLRP3 Inflammasome
by: Gu W, et al.
Published: (2024)

lncRNA MALAT1 Accelerates Skeletal Muscle Cell Apoptosis and Inflammatory Response in Sepsis by Decreasing BRCA1 Expression by Recruiting EZH2
by: Hui Yong, et al.
Published: (2020)

Ginsenoside Rg3 alleviates septic liver injury by regulating the lncRNA TUG1/miR-200c-3p/SIRT1 axis
by: Pan Wu, et al.
Published: (2021)

NLRP3 inflammasome in atherosclerosis: Mechanisms and targeted therapies
by: Pengfei Chen, et al.
Published: (2024)

The role of NLRP3 inflammasome in hepatocellular carcinoma
by: Huijie Zhao, et al.
Published: (2023)

Corylin inhibits LPS-induced inflammatory response and attenuates the activation of NLRP3 inflammasome in microglia
by: Ming-Yii Huang, et al.
Published: (2018)

Targeting NLRP3 Inflammasome Alleviates Synovitis by Reducing Pyroptosis in Rats with Experimental Temporomandibular Joint Osteoarthritis
by: Yinzi Xin, et al.
Published: (2022)

NLRP3 Inflammasome Pharmacological Inhibitors in Glycyrrhiza for NLRP3-Driven Diseases Treatment: Extinguishing the Fire of Inflammation
by: Wang Z, et al.
Published: (2022)

Neurodegenerative Disease and the NLRP3 Inflammasome
by: Jonathan A. Holbrook, et al.
Published: (2021)

Spotlight on the NLRP3 inflammasome pathway
by: Groslambert M, et al.
Published: (2018)

The role of the NLRP3 inflammasome in gout
by: Sarah R Kingsbury, et al.
Published: (2011)

Inhibition of the PERK/TXNIP/NLRP3 Axis by Baicalin Reduces NLRP3 Inflammasome-Mediated Pyroptosis in Macrophages Infected with Mycobacterium tuberculosis
by: Yan Fu, et al.
Published: (2021)

The effects of lncRNA MALAT1 on proliferation, invasion and migration in colorectal cancer through regulating SOX9
by: Yuanlin Xu, et al.
Published: (2018)

Retraction Notice to: lncRNA MALAT1 Accelerates Wound Healing of Diabetic Mice Transfused with Modified Autologous Blood via the HIF-1α Signaling Pathway
by: Xiao-Qian Liu, et al.
Published: (2022)

LncRNA XIST restrains the activation of Müller cells and inflammation in diabetic retinopathy via stabilizing SIRT1
by: Jiayu Zhang, et al.
Published: (2021)

Fucoidan Alleviates Renal Fibrosis in Diabetic Kidney Disease via Inhibition of NLRP3 Inflammasome-Mediated Podocyte Pyroptosis
by: Mei-Zi Wang, et al.
Published: (2022)

Effects of 1,25-dihydroxyvitamin D3 on experimental periodontitis and AhR/NF-κB/NLRP3 inflammasome pathway in a mouse model
by: Hao Li, et al.
Published: (2019)